"Neoplastic Processes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.
| Descriptor ID |
D009385
|
| MeSH Number(s) |
C04.697 C23.550.727
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplastic Processes".
Below are MeSH descriptors whose meaning is more specific than "Neoplastic Processes".
This graph shows the total number of publications written about "Neoplastic Processes" by people in this website by year, and whether "Neoplastic Processes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplastic Processes" by people in Profiles.
-
Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer Patients. Cells. 2022 07 29; 11(15).
-
Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021 02; 21(2):71-88.
-
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput Biol. 2014 Aug; 10(8):e1003665.
-
Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom Med. 2011 Nov-Dec; 73(9):724-30.
-
Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development. Endocrinology. 2011 Jun; 152(6):2164-73.
-
Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. J Proteome Res. 2011 Jan 07; 10(1):200-9.
-
siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model. PLoS One. 2010 Sep 20; 5(9):e12860.
-
Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers. Cancer Epidemiol Biomarkers Prev. 2003 Jul; 12(7):593-6.
-
Biology of colorectal liver metastases. Surg Oncol Clin N Am. 2003 Jan; 12(1):135-50.
-
Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas. J Soc Gynecol Investig. 1999 Jul-Aug; 6(4):213-21.